Anagrelide
Anagrelide Hydrochloride is a generic prescription drug available as oral capsules in 0.5 mg and 1 mg strengths. It reduces platelet production in the blood and is used to treat conditions like essential thrombocythemia. Manufactured by Chartwell RX, LLC under ANDA076683. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Anagrelide Hydrochloride is a generic prescription drug available as oral capsules in 0.5 mg and 1 mg strengths. It reduces platelet production in the blood and is used to treat conditions like essential thrombocythemia. Manufactured by Chartwell RX, LLC under ANDA076683. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Anagrelide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Anagrelide — ANDA 076811 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076811"
}
]
|
| identifier | ANDA076811 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Anagrelide |
